SCHEMBL5389348

SCHEMBL5389348

Cc1ccccc1C(Br)C(Br)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.54
ACP3 P15309 1/20 0.44
ESR1 P03372 1/20 0.42
ALDH1A1 P00352 3/20 0.39
CYP2C19 P33261 2/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
MME P08473 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP2D6 P10635 1/20 0.35
SRC P12931 1/20 0.35
CTSA P10619 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8129146 0.82 ACP3 (0.46) CYP1A2ACP3ESR1ALDH1A1CES2
SCHEMBL76634 0.82 ACP3 (0.46) CYP1A2ACP3ESR1ALDH1A1CES2
SCHEMBL5925059 0.82 ACP3 (0.46) CYP1A2ACP3ESR1ALDH1A1CES2
SCHEMBL11458010 0.79 ESR1 (0.38) CYP1A2ACP3ESR1ALDH1A1MEN1
SCHEMBL31198070 0.78 TDP1 (0.44) ESR1ALDH1A1MEN1KMT2A
SCHEMBL4370114 0.77 ACP3 (0.48) ACP3ESR1ALDH1A1HPGDLMNA
SCHEMBL28459728 0.77 CYP2D6 (0.50) ACP3ESR1ALDH1A1HPGDLMNA
SCHEMBL2206363 0.77 SRC (0.50) ACP3ESR1ALDH1A1HPGDLMNA
SCHEMBL30136352 0.77 SRC (0.50) ACP3ESR1ALDH1A1HPGDLMNA
SCHEMBL6207207 0.76 CYP1A2 (0.54) CYP1A2ACP3ALDH1A1CYP2C19CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7300939-B2 Substituted 1-propiolylpiperazine compounds, their preparation and use GRUENENTHAL GMBH (DE) 2007-11-27 US disclosed
US-20070112011-A1 Substituted 1-propiolylpiperazine compounds, their preparation and use GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112011-A1 Substituted 1-propiolylpiperazine compounds, their preparation and use GRM5, GRIK5, GRM1 CYP1A2 1379/4885ACP3 2835/4885ESR1 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.